SBIR Phase II: A Label-Free SERS-Capture Assay in Microchips for Biological Warfare Agents

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0956170
Agency Tracking Number: 0810335
Amount: $501,904.00
Phase: Phase II
Program: SBIR
Awards Year: 2010
Solicitation Year: 2010
Solicitation Topic Code: EO
Solicitation Number: NSF 07-586
Small Business Information
DUNS: 076890222
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Frank Inscore
 (860) 635-9800
Business Contact
 Frank Inscore
Phone: (860) 635-9800
Research Institution
This Small Business Innovation Research (SBIR) Phase II project will develop a prototype analyzer that can detect, identify, and quantify the presence of Category A (B and C) bioagents at the required specificity and sensitivity (e.g. in air 104 spores/m3, 100 organisms/m3 and 2-300 mg toxin/m3) within 10 minutes. The analyzers will incorporate a novel surface-enhanced Raman spectroscopy (SERS)-based assay into sample systems read by a portable Raman spectrometer. The assays will be functionalized to selectively capture specific bioagents and generate unique SER spectra when irradiated by the analyzer laser. During Phase I, feasibility was demonstrated by selectively binding and detecting 25 ppm B. cereus (a B. anthracis surrogate) in the presence of 250 ppm B. subtilis. During Phase II, the assays will be developed to detect several real agents, such as B. anthracis (anthrax), Yersinia pestis (Plague), Francisella tularensis (Tularemia), and Clostridium botulinum (Botulism). The assays will then be incorporated into a product prototype that autonomously detects aerosolized bioagents. The analytical capabilities of the prototype will be validated at the US Army's Edgewood Chemical Biological Center. The broader/commercial impact of this project will provide a bioagent detector with the necessary sensitivity and speed to save lives and reduce substantially the terror associated with biological attacks. The continued presence of US military personnel in the Middle East has produced a persistent fear that biological warfare agents may be used by terrorists against civilian and military personnel at home and abroad. The proposed analyzer will allow measurement of such bioagents within 10 minutes, a vast improvement over the 2-3 hours required by current technology. Initially, the proposed detector will be used to protect military bases. Once established, the application of this product will be expanded to civilian applications, such as transit systems, high profile buildings (federal, financial, Fortune 500), stadiums, airports, and malls. The US military and civilian market is currently estimated at $0.5 Billion.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government